XML 105 R89.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE-BASED COMPENSATION, Share Options Activity (Details) - Stock Options [Member]
12 Months Ended
Dec. 08, 2023
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Number of Share Options [Roll Forward]        
Outstanding, beginning balance (in shares) | shares   21,603,366 9,225,271  
Granted (in shares) | shares   0 12,797,063  
Exercised (in shares) | shares   0 (51,468)  
Forfeited (in shares) | shares   (116,125) (334,167)  
Expired (in shares) | shares   (19,111) (33,333)  
Outstanding, ending balance (in shares) | shares   2,025,115 21,603,366 9,225,271
Outstanding, beginning balance after share consolidation (in shares) | shares [1]   2,160,351    
Expected to vest, period end (in shares) | shares   591,600    
Exercisable, period end (in shares) | shares   1,433,515    
Weighted Average Exercise Price [Abstract]        
Outstanding, beginning balance (in dollars per share) | $ / shares   $ 1.44 $ 1.1  
Granted (in dollars per share) | $ / shares   0 1.68  
Exercised (in dollars per share) | $ / shares   0 0.28  
Forfeited (in dollars per share) | $ / shares   16.8 1.68  
Expired (in dollars per share) | $ / shares   13.09 1.68  
Outstanding, ending balance (in dollars per share) | $ / shares   14.26 $ 1.44 $ 1.1
Outstanding, beginning balance after share consolidation (in dollars per share) | $ / shares [1]   14.38    
Expected to vest, period end (in dollars per share) | $ / shares   17.05    
Exercisable, period end (in dollars per share) | $ / shares   $ 13.1    
Weighted Average Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]        
Outstanding, weighted average remaining contractual term   4 years 9 months 21 days 5 years 11 months 26 days [1] 2 years 7 months 6 days
Expected to vest, weighted average remaining contractual term   8 years 1 month 17 days    
Exercisable, weighted average remaining contractual term   3 years 5 months 8 days    
Outstanding, aggregate intrinsic value | $   $ 0 $ 721,210 [1] $ 42,799,081
Expected to vest, aggregate intrinsic value | $   0    
Exercisable, aggregate intrinsic value | $   $ 0    
Share consolidation 0.1      
[1] On September 1, 2023 the Company held its annual general meeting of shareholders where among other proposals, the shareholders of the Company did approve the consolidation of the ordinary shares of the Company on a one-for-ten (1:10) basis with effect from December 8, 2023 (the “Share Consolidation”). The one-for-ten reverse stock split decreased the number of outstanding shares and increased net loss per common share. All per share and share amounts presented have been retroactively adjusted for the effect of this share consolidation for all periods presented.